ST. LUKES BEHAVIORAL HEALTH CENTER
1. Target Overview & Investment Thesis
ST. LUKES BEHAVIORAL HEALTH CENTER is a 127-bed safety-net/medicaid heavy in MARICOPA, AZ with $37.7M in net patient revenue and a -10.8% operating margin. The hospital serves a payer mix of 6.4% Medicare, 30.7% Medicaid, and 63.0% commercial.
Thesis: Undervalued. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.8% to -3.5% (+736bps).
| Net Revenue HCRIS | $37.7M |
| Current EBITDA COMPUTED | $-4.1M |
| Operating Margin COMPUTED | -10.8% |
| Occupancy HCRIS | 80.0% |
| Revenue / Bed COMPUTED | $297K |
| Net-to-Gross HCRIS | 34.7% |
| Distress Probability ML | 48.8% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -10.8% places it below the state median. Among 47 size-comparable peers (64-254 beds), the median margin is 2.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (64-254), prioritizing same-state peers. 47 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. LUKES BEHAVIORAL HEALTH CE (Target) | AZ | 127 | $37.7M | -10.8% |
| BANNER GATEWAY MEDICAL CENTER | AZ | 185 | $573.8M | 5.2% |
| FLAGSTAFF MEDICAL CENTER | AZ | 242 | $477.9M | -0.8% |
| YAVAPAI REGIONAL MEDICAL CENTE | AZ | 218 | $456.9M | -2.2% |
| MERCY GILBERT MEDICAL CENTER | AZ | 197 | $381.9M | 6.3% |
| KINGMAN REGIONAL MEDICAL CENTE | AZ | 196 | $373.6M | -6.0% |
| HONORHEALTH DEER VALLEY MED CT | AZ | 204 | $372.1M | 3.3% |
| NORTHWEST MEDICAL CENTER | AZ | 253 | $318.3M | -1.0% |
| ABRAZO WEST CAMPUS | AZ | 207 | $303.3M | 22.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $792K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $755K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $747K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $459K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $24K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-4.1M |
| + RCM Uplift | +$2.8M |
| Pro Forma EBITDA | $-1.3M |
| Current Margin | -10.8% |
| Pro Forma Margin | -3.5% |
| WC Released (1x) | $1.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-6.3M | $795K | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-6.3M | $-1.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-5.7M | $6.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-5.7M | $4.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-6.9M | $-11.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-6.9M | $-14.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (30.7%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 47 hospitals with 64-254 beds
- Same-state prioritization (n=48)
- Comp margins: P25=-6.2% / P50=2.2% / P75=10.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.